An explosion in the popularity of weight-loss aiding drugs like Ozempic and Wegovy has had retailers in a panic over how much shoppers’ waning appetite will hurt their bottom line.
Now, the maker of KitKat appears to be preparing for a downturn by creating items that might complement the typical GLP-1 user.
